{"id":2832,"date":"2024-02-29T08:43:26","date_gmt":"2024-02-29T08:43:26","guid":{"rendered":"https:\/\/lunchboxrd.com\/how-cancer-cells-hide-from-the-immune-system-in-early-stages-1709196206\/"},"modified":"2024-02-29T08:43:27","modified_gmt":"2024-02-29T08:43:27","slug":"how-cancer-cells-hide-from-the-immune-system-in-early-stages-1709196206","status":"publish","type":"post","link":"https:\/\/lunchboxrd.com\/how-cancer-cells-hide-from-the-immune-system-in-early-stages-1709196206\/","title":{"rendered":"How Cancer Cells Hide from the Immune System in Early Stages"},"content":{"rendered":"

Cancer cells have a notorious ability to evade the body’s immune defenses, a skill that allows them to grow and spread seemingly undetected. A new research collaboration between MIT and Dana-Farber Cancer Institute has shed light on a key player in this stealth operation: the SOX17 gene. Their findings suggest that early-stage cancer cells ramp up the activity of SOX17 as a means to hide from immune responses, setting the stage for tumor development.<\/p>\n

\n
\n

On this page:<\/p>\n<\/span><\/div>\n